Sisli Hamidiye Etfal Research and Training Hospital
Istanbul, 34771, Turkey (Türkiye)
NCT Number: NCT04956562
Effect of Inactivated COVID-19 Vaccine (Sinovac) on survival in intensive care unit, Single Center Experience
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Istanbul, 34771, Turkey (Türkiye)
Turkey has started vaccinate healthcare professionals at 13 January 2021 by Sinovac vaccine and declared a step by step inclusion schedule The primary aim of the study is to compare clinical, laboratory and survival data of COVID-19 patients who were vaccinated at least 14 days before enrollment to the study with COVID-19 patients not vaccinated although they would have. The secondary aim is to compare age of enrolled patients to ICU due to SARS-CoV-2 infection with patients admitted to ICU before start of vaccination program.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days
If the patient dies, we have reached an outcome
Sisli Hamidiye Etfal Training and Research Hospital
Other
Effect of Inactivated COVID-19 Vaccine, Sinovac on Survival in Intensive Care Unit
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07601113
Breast Diseases, Breast Neoplasms
Kaohsiung City, Taiwan
View Trial DetailsNCT06884839
Colonic Diseases, Colorectal Cancer
Minya, Minya Governorate, Egypt
View Trial DetailsNCT03624595
Cardiac Surgery, Cardiopulmonary Bypass
Beijing, Beijing Municipality, China
View Trial DetailsNCT05343260
Aged, Anesthesia, Inhalation
Beijing, Beijing Municipality, China
View Trial Details